Skip to main content
Samuel Frank, MD, Neurology, Boston, MA

Samuel Arthur Frank MD

Movement Disorder


Professor of Clinical Neurology at Beth Israel Deaconess Medical Center/Harvard Medical School

Join to view full profile
  • 330 Brookline AveShapiro 8Boston, MA 02215

  • Phone+1 617-667-0519

  • Fax+1 617-975-5454

Dr. Frank is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Samuel Frank is a neurologist based in Boston, MA, specializing in movement disorders. He completed his medical degree at Boston University School of Medicine in 1998 and his residency in neurology at the University of Rochester Medical Center in 2002. He holds an academic position as an Associate Professor at Beth Israel Deaconess Medical Center since 2015. Dr. Frank has clinical expertise in movement disorders. He has published multiple articles on topics such as Huntington's disease and Parkinson's disease and has been involved in many clinical trials related to these conditions. His achievements include being recognized as a Fellow by both the American Academy of Neurology and the American Neurological Association and receiving several awards throughout his career.

Education & Training

  • University of Rochester Medical Center
    University of Rochester Medical CenterResidency, Neurology, 1999 - 2002
  • University of Rochester Medical Center
    University of Rochester Medical CenterInternship, Internal Medicine, 1998 - 1999
  • Boston University School of Medicine
    Boston University School of MedicineClass of 1998
  • University of Rochester
    University of RochesterB.A., Biology, 1993

Certifications & Licensure

  • ME State Medical License
    ME State Medical License Current
  • MA State Medical License
    MA State Medical License 2004 - 2027
  • NH State Medical License
    NH State Medical License 2024 - 2024
  • NY State Medical License
    NY State Medical License 1999 - 2004
  • Neurology
    American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • Fellow American Academy of Neurology, 2017
  • Fellow American Neurological Association, 2014
  • Neurology Alumni Award University of Rochester, 2013

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Patient-Reported Outcome Measures in Huntington Disease: Quality of Life in Neurological Disorders (Neuro-Qol) Social Functioning Measures  
    Carlozzi NE, Hahn EA, Goodnight SM, Kratz AL, Paulsen JS, Stout JC, Frank S, Miner JA, Cella D, Gershon RC, Schilling SG, Ready RE, Psychol Assess, 1/29/2017
  • Deutetrabenazine: A Review in Chorea Associated with Huntington’s Disease  
    Heo Y-A and Scott LJ, Drugs, 1/27/2017
  • Patient-reported Outcomes in Huntington’s Disease: Quality of Life in Neurological Disorders (Neuro-QoL) and Huntington’s Disease Health-Related Quality of Life (HDQLI...  
    Carlozzi NE, Ready RE, Frank S, Cella D, Hahn EA, Goodnight SM, Schilling SG, Boileau NR, Dayalu P, Mov Disord, 1/27/2017

Books/Book Chapters

Abstracts/Posters

  • Evaluating swallowing function in patients with Huntington Disease enrolled in the First-HD Study.
    Samuel Frank, Sarah Janicki, Daniel Claassen, David Oakes, Victor Sung, Christina Vaughan and Claudia Testa on behalf of the Huntington Study Group First-HD Investigators, International Parkinson Disease and Movement Disorder Congress, 1/22/2016
  • Deutetrabenazine Effect on Total Motor Score in Patients with Huntington Disease (First-HD)
    Samuel Frank, David Stamler, Victor Sung, Daniel Claassen, Sarah Janicki, Clement Loy, Erin Furr-Stimming, David Oakes and Claudia Testa on behalf of the Huntington St..., American Academy of Neurology, Vancouver, British Columbia, Canada, 1/19/2016
  • Rating Swallowing Function in Patients with Huntington Disease Enrolled in the First-HD Study.
    Daniel Claassen, Samuel Frank, David Stamler, Victor Sung, Sarah Janicki, David Oakes, Christina Vaughan and Claudia Testa on behalf of the Huntington Study Group Firs..., American Academy of Neurology, 1/18/2016

Lectures

  • Huntington’s Disease 
    Beth Israel Deaconess Medical Center - 1/1/2018
  • VMAT2 Inhibitors: The FDA Approval Process and Community Impact. 
    MGH - 1/1/2017
  • An Interdisciplinary Approach to Caring for Individuals Affected by Huntington’s Disease and their Families 
    MGH - 1/1/2017

Other

  • Are We Making Progress in the Management of Huntington Disease? 
    Frank S, Medscape video, CME
    1/16/2016
  • Updates from Berlin: New Developments in Huntington's Disease. 
    Frank S, Vindico video, CME
    1/15/2016
  • Parkinson’s Disease and Michael J. Fox Foundation study 
    Frank S, New England Cable News
    1/26/2014

Press Mentions

  • Sage Therapeutics to Host Sage Science Spotlight: SAGE-718 in Depth
    Sage Therapeutics to Host Sage Science Spotlight: SAGE-718 in DepthMay 13th, 2021
  • Possible Huntington's Disease Treatment Being Tested in Boston
    Possible Huntington's Disease Treatment Being Tested in BostonSeptember 11th, 2019
  • Even Mild Traumatic Brain Injury May Increase Parkinson’s Risk
    Even Mild Traumatic Brain Injury May Increase Parkinson’s RiskApril 18th, 2018

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: